Invesco Ltd. Arcturus Therapeutics Holdings Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Invesco Ltd. holds 18,835 shares of ARCT stock, worth $318,499. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,835

Previous 18,679 0.84%

Holding current value

$318,499

Previous $454,000 3.74%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$18.08 - $25.38 $2,820 - $3,959	156 Added 0.84%	18,835 $437,000
Q2 2024 Aug 13, 2024	SELL	$24.35 - $44.39 $30,997 - $56,508	-1,273 Reduced 6.38%	18,679 $454,000
Q1 2024 May 14, 2024	BUY	$31.23 - $42.99 $209,116 - $287,861	6,696 Added 50.51%	19,952 $673,000
Q4 2023 Feb 12, 2024	SELL	$17.71 - $32.97 $2.13 Million - $3.97 Million	-120,315 Reduced 90.08%	13,256 $417,000
Q3 2023 Nov 13, 2023	BUY	$25.44 - $37.35 $3.13 Million - $4.59 Million	122,953 Added 1157.97%	133,571 $3.41 Million
Q2 2023 Aug 11, 2023	BUY	$23.94 - $32.36 $17,571 - $23,752	734 Added 7.43%	10,618 $304,000
Q1 2023 May 12, 2023	SELL	$14.72 - $23.97 $227,600 - $370,624	-15,462 Reduced 61.0%	9,884 $236,000
Q4 2022 Feb 13, 2023	SELL	$14.14 - $23.06 $13,970 - $22,783	-988 Reduced 3.75%	25,346 $429,000
Q3 2022 Nov 14, 2022	BUY	$13.05 - $22.13 $2,309 - $3,917	177 Added 0.68%	26,334 $391,000
Q2 2022 Aug 15, 2022	BUY	$12.26 - $31.17 $54,152 - $137,677	4,417 Added 20.32%	26,157 $412,000
Q1 2022 May 16, 2022	BUY	$17.64 - $39.57 $237,663 - $533,126	13,473 Added 162.97%	21,740 $586,000
Q4 2021 Feb 14, 2022	SELL	$34.2 - $47.56 $45,349 - $63,064	-1,326 Reduced 13.82%	8,267 $306,000
Q3 2021 Nov 15, 2021	BUY	$27.88 - $58.25 $23,391 - $48,871	839 Added 9.58%	9,593 $459,000
Q2 2021 Aug 17, 2021	BUY	$25.79 - $42.11 $79,407 - $129,656	3,079 Added 54.26%	8,754 $295,000
Q1 2021 May 17, 2021	BUY	$38.75 - $86.92 $219,906 - $493,271	5,675 New	5,675 $234,000
Q4 2020 Feb 16, 2021	SELL	$34.61 - $123.66 $291,208 - $1.04 Million	-8,414 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$37.49 - $63.19 $7.97 Million - $13.4 Million	-212,490 Reduced 96.19%	8,414 $362,000
Q2 2020 Aug 14, 2020	BUY	$12.66 - $58.27 $2.8 Million - $12.9 Million	220,904 New	220,904 $10.3 Million

Others Institutions Holding ARCT

# of Institutions

179

Shares Held

25.6M

Call Options Held

195K

Put Options Held

133K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $449M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account